Trial intelligence / Profile preview

Low-dose esketamine for sleep quality, postoperative analgesia and inflammation after cesarean section

ChiCTR2500099435Phase 4Recruiting

Sponsor
Chengdu Pidu District Maternal and Child Health Care Hospital
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in sleep disorder, postoperative pain, post-operative inflammation and 1 more comparing Esketamine low-dose arm with Placebo (normal saline) control arm (2 arms). Primary endpoints: Sleep quality and Visual analog score. Started Mar 2025; status: recruiting.

02

Drugs

esketamine
03

Conditions

sleep disorderpostoperative painpost-operative inflammationpostpartum depression (PPD)

Beyond the preview

Go deeper on ChiCTR2500099435.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500099435.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call